文献速递急性肾损伤肾血管病与高血压

进行性细胞衰老介导缺血性肾病肾功能障碍

Progressive Cellular Senescence Mediates Renal Dysfunction in Ischemic Nephropathy.
PubMed 文献 · J Am Soc Nephrol · 2021-06-16

该研究在单侧肾动脉狭窄(RAS)小鼠模型中证实,肾小管细胞衰老(p16、p19、p21上调)与 stenotic 肾脏功能障碍及损伤相关;选择性清除 p16 高表达细胞或使用达沙替尼联合槲皮素可改善肾功能,人狭窄肾脏亦存在细胞衰老。

要点

  • RAS 后肾小管细胞发生衰老并伴间充质转化,与肾功能障碍相关。
  • RAS 后 1、2 或 4 周开始清除 p16 高表达细胞可改善 stenotic 肾功能,但立即治疗无效。
  • 达沙替尼联合槲皮素清除 p21 阳性细胞更有效减轻肾功能障碍和损伤。

核心结论

  • 适应不良的肾小管细胞衰老(p16、p19、p21上调)与慢性缺血性肾功能障碍和损伤相关,支持开发抗衰老策略延缓慢性缺血性肾损伤。

研究设计与样本

  • 在 INK-ATTAC 转基因和野生型 C57BL/6 小鼠中通过单侧 RAS 诱导慢性肾缺血,用活体 micro-MRI 评估肾功能和组织损伤。
  • 对小鼠健康和 stenotic 肾脏进行无偏单细胞 RNA 测序,并在人 stenotic 肾脏中研究细胞衰老。

主要发现

  • RAS 后 1、2 或 4 周开始腹腔注射 AP20187 选择性清除 p16Ink4a 高表达细胞,可减轻细胞衰老并改善 stenotic 肾功能;但 RAS 诱导后立即开始治疗未成功。
  • 口服达沙替尼联合槲皮素在 C57BL/6 RAS 小鼠中更有效清除 p21(Cdkn1a)阳性细胞并减轻肾功能障碍和损伤。
  • 单细胞 RNA 测序识别出 stenotic 肾脏上皮细胞同时发生间充质转化和衰老,人损伤 stenotic 肾脏也表现细胞衰老。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Peripheral vascular diseases may induce chronic ischemia and cellular injury distal to the arterial obstruction. Cellular senescence involves proliferation arrest in response to stress, which can damage neighboring cells. Renal artery stenosis (RAS) induces stenotic-kidney dysfunction and injury, but whether these arise from cellular senescenceand their temporal pattern remain unknown. METHODS: Chronic renal ischemia was induced in transgenic INK-ATTAC and wild type C57BL/6 mice by unilateral RAS, and kidney function (in vivo micro-MRI) and tissue damage were assessed. Mouse healthy and stenotic kidneys were analyzed using unbiased single-cell RNA-sequencing. To demonstrate translational relevance, cellular senescence was studied in human stenotic kidneys. RESULTS: Using intraperitoneal AP20187 injections starting 1, 2, or 4 weeks after RAS, selective clearance of cells highly expressing p16Ink4a attenuated cellular senescence and improved stenotic-kidney function; however, starting treatment immediately after RAS induction was unsuccessful. Broader clearance of senescent cells, using the oral senolytic combination dasatinib and quercetin, in C57BL/6 RAS mice was more effective in clearing cells positive for p21 (Cdkn1a) and alleviating renal dysfunction and damage. Unbiased, single-cell RNA sequencing in freshly dissociated cells from healthy and stenotic mouse kidneys identified stenotic-kidney epithelial cells undergoing both mesenchymal transition and senescence. As in mice, injured human stenotic kidneys exhibited cellular senescence, suggesting this process is conserved. CONCLUSIONS: Maladaptive tubular cell senescence, involving upregulated p16 (Cdkn2a), p19 (Cdkn2d), and p21 (Cdkn1a) expression, is associated with renal dysfunction and injury in chronic ischemia. These findings support development of senolytic strategies to delay chronic ischemic renal injury.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Kim SR, Puranik AS, Jiang K, et al. Progressive Cellular Senescence Mediates Renal Dysfunction in Ischemic Nephropathy. J Am Soc Nephrol. 2021. PMID: 34135081. doi:10.1681/ASN.2020091373

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。